Skip to content
Menu

STAAR Surgical Company STAA

Full chart Compare
Set alert

Price alert · STAA

All alert types
25.03 USD -0.32 (-1.26%)

Regular-session close

24.68 -0.35 -1.40%

After hours · Nov 19, 4:15 PM ET

24.77 Day range 25.93
15.59 52-week range 35.87
YTD
+8.40%
1 year
-5.37%

5D +1.46 (+6.06%)

24252627WedThuFriMonTue25.56
Market cap
1.26B
Revenue (ttm)
328.27M
Profit margin
0.16%
EPS (ttm)
0.01
Shares out
50.20M
P/E ratio
2503.00
Forward P/E
22.10
YTD return
+8.40%
1-year return
-5.37%
50-day average
23.09
Volume
557.78K
Avg volume
841.65K
Open
25.19
Previous close
25.35
Day's range
24.77 – 25.93
52-week range
15.59 – 35.87
Beta
1.20
Analysts
Buy
Price target
28.56 (+14.1%)
Earnings date
Mar 2, 2027

Key statistics

200-day average
24.01
Enterprise value
1.10B
PEG ratio
0.76
Price / sales
3.83
Price / book
3.34
Revenue growth
-12.00%
Free cash flow
41.75M
Total cash
206.41M
Total debt
33.64M
Return on equity
0.14%
Short % of float
15.15%

Fundamental scorecard

14 of 25 checks passed on STAA’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 2 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Oct 2, 2026.

Financials — quick view

All financials
STAA Revenue — quarterly 83.41M
STAA Net income — quarterly 5.58M
STAA EPS — quarterly 0.11

Earnings

STAA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 2, 2027Jan 2, 2027-0.04608———
Nov 4, 2026Oct 2, 20260.050750.11+0.06+116.75%
Aug 12, 2026Jul 3, 20260.22140.16-0.06-27.73%
May 13, 2026Apr 3, 20260.054220.38+0.33+600.85%
Mar 3, 2026Jan 2, 20260.18-0.20-0.38-211.11%
Nov 5, 2025Sep 26, 20250.180.46+0.28+155.56%

Upgrades / downgrades

STAA analyst upgrades and downgrades
DateFirmActionFromTo
Sep 29, 2026StifelupHoldBuy
Sep 22, 2026JefferiesmainBuyBuy
Aug 17, 2026StifelmainHoldHold
Aug 13, 2026UBSmainSellSell
Aug 13, 2026JefferiesmainBuyBuy
Aug 13, 2026WedbushmainOutperformOutperform

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
staar.com

News

Your note

Sign in to keep a note on STAA — it syncs with the Stock Master app.

Insider holders

STAA insider holders
InsiderRelationLatest transactionDateShares held
ANDREWS DEBORAH JChief Financial OfficerConversion of Exercise of derivative securityAug 13, 202638,910
BROADWOOD PARTNERS, L.P.Beneficial Owner of more than 10% of a Class of SecurityPurchaseMar 12, 20260
BUTCHER ARTHUR CDirectorConversion of Exercise of derivative securityJun 17, 20269,549
FARRELL STEPHEN CChief Executive OfficerConversion of Exercise of derivative securityMar 4, 202535,156
FOUST WARRENChief Executive OfficerConversion of Exercise of derivative securityAug 13, 202695,816
JIANG WEIDirectorConversion of Exercise of derivative securityJun 17, 202677,127

Institution ownership

STAA institution ownership
Holder% heldSharesValueReported
Broadwood Capital, Inc.32.12%16,123,842403.58MSep 29, 2026
Blackrock Inc.10.00%5,019,284125.63MSep 29, 2026
Madison Avenue Partners, LP9.74%4,891,995122.45MSep 29, 2026
Yunqi Capital Ltd6.49%3,257,13081.53MSep 29, 2026
Vanguard Portfolio Management LLC3.64%1,827,07445.73MSep 29, 2026
State Street Corporation2.73%1,369,16434.27MSep 29, 2026

Fund ownership

STAA fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF3.57%1,790,30944.81MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.89%949,46023.76MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.57%790,55819.79MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.36%684,66417.14MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.14%570,68814.28MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund0.78%392,9909.84MJun 29, 2026